Reviewed,
UniProtKB/Swiss-Prot Q5QJU3 (ACER2_HUMAN)
Last modified
November 3, 2009.
Version 36.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Alkaline ceramidase 2 Short name=Alkaline CDase 2 Short name=AlkCDase 2 Short name=haCER2 EC=3.5.1.23 Alternative name(s): N-acylsphingosine amidohydrolase 3-like Acylsphingosine deacylase 3-like | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 275 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at transcript level. |
General annotation (Comments)
| Function | Hydrolyzes the sphingolipid ceramide into sphingosine and free fatty acid. Regulates the maturation of integrin beta-1 (ITGB1) by controlling the generation of sphingosine in the Golgi complex. Inhibits cell adhesion by reducing the level of ITGB1 in the cell surface. May have a role in cell proliferation and apoptosis that seems to depend on the balance between sphingosine and sphingosine-1-phosphate. Ref.1 Ref.5 |
| Catalytic activity | N-acylsphingosine + H2O = a carboxylate + sphingosine. |
| Subcellular location | Golgi apparatus membrane; Multi-pass membrane protein. Ref.1 |
| Tissue specificity | Highly expressed in placenta. Ref.1 |
| Sequence similarities | Belongs to the alkaline ceramidase family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Lipid metabolism |
| Cellular component | Golgi apparatus Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Transmembrane |
| Molecular function | Hydrolase |
| PTM | Glycoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | ceramide metabolic process Inferred from electronic annotation. Source: InterPro |
| Cellular component | Golgi membrane Ref.1 Inferred from electronic annotation. Source: InterPro endoplasmic reticulum membraneInferred from electronic annotation. Source: InterPro integral to membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | ceramidase activity Ref.1 Inferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q5QJU3-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q5QJU3-2) The sequence of this isoform differs from the canonical sequence as follows: 1-49: Missing. | ||||||
| Isoform 3 (identifier: Q5QJU3-3) The sequence of this isoform differs from the canonical sequence as follows: 1-49: Missing. 169-189: CDNMRVFKLGLFSGLWWTLAL → HERNQRRRHRKGGQQGGGDKV 190-275: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 275 | 275 | Alkaline ceramidase 2 | PRO_0000247748 | |||||
Regions | |||||||||
| Transmembrane | 33 – 53 | 21 | Potential | ||||||
| Transmembrane | 63 – 83 | 21 | Potential | ||||||
| Transmembrane | 87 – 107 | 21 | Potential | ||||||
| Transmembrane | 125 – 142 | 18 | Potential | ||||||
| Transmembrane | 144 – 164 | 21 | Potential | ||||||
| Transmembrane | 174 – 194 | 21 | Potential | ||||||
| Transmembrane | 212 – 232 | 21 | Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 23 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 49 | 49 | Missing in isoform 2 and isoform 3. | VSP_020033 | |||||
| Alternative sequence | 169 – 189 | 21 | CDNMR…WTLAL → HERNQRRRHRKGGQQGGGDK V in isoform 3. | VSP_020034 | |||||
| Alternative sequence | 190 – 275 | 86 | Missing in isoform 3. | VSP_020035 | |||||
| Natural variant | 134 | 1 | A → V: dbSNP rs10964136. | VAR_027150 | |||||
Experimental info | |||||||||
| Sequence conflict | 274 | 1 | I → T in AAQ85132. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Golgi alkaline ceramidase regulates cell proliferation and survival by controlling levels of sphingosine and S1P." Xu R., Jin J., Hu W., Sun W., Bielawski J., Szulc Z., Taha T., Obeid L.M., Mao C. FASEB J. 20:1813-1825(2006) [PubMed: 16940153] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [2] | "Large-scale cDNA transfection screening for genes related to cancer development and progression." Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X. Gu J.Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004) [PubMed: 15498874] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). |
| [3] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed: 15164053] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Placenta. |
| [5] | "Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion." Sun W., Hu W., Xu R., Jin J., Szulc Z.M., Zhang G., Galadari S.H., Obeid L.M., Mao C. FASEB J. 23:656-666(2009) [PubMed: 18945876] [Abstract] Cited for: FUNCTION. |
Cross-references
Sequence databases | |
|---|---|
| AY312516 mRNA. Translation: AAQ85132.1. AF370405 mRNA. Translation: AAQ15241.1. AL158206, AL391834 Genomic DNA. Translation: CAH73022.1. AL391834, AL158206 Genomic DNA. Translation: CAM21146.1. BC092487 mRNA. Translation: AAH92487.1. | |
| IPI | IPI00420054. IPI00479560. IPI00783055. |
| RefSeq | NP_001010887.2. |
| UniGene | Hs.41379 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q5QJU3. |
Proteomic databases | |
| PRIDE | Q5QJU3. |
Genome annotation databases | |
| Ensembl | ENST00000340967; ENSP00000342609; ENSG00000177076; Homo sapiens. [Genome view] ENST00000380376; ENSP00000369735; ENSG00000177076; Homo sapiens. [Genome view] |
| GeneID | 340485. |
| KEGG | hsa:340485. |
| UCSC | uc003zny.1. human. uc003znz.1. human. |
Organism-specific databases | |
| CTD | 340485. |
| GeneCards | GC09P019400. |
| HGNC | HGNC:23675. ACER2. |
| HPA | HPA014092. |
| PharmGKB | PA134968664. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOGENOM | Q5QJU3. |
| HOVERGEN | Q5QJU3. |
| OMA | CANKKSP. |
Enzyme and pathway databases | |
| BRENDA | 3.5.1.23. 247. |
| Reactome | REACT_602. Metabolism of lipids and lipoproteins. |
Gene expression databases | |
| ArrayExpress | Q5QJU3. |
| Bgee | Q5QJU3. |
| CleanEx | HS_ACER2. |
| Genevestigator | Q5QJU3. |
Family and domain databases | |
| InterPro | IPR008901. APHC. [Graphical view] |
| Pfam | PF05875. aPHC. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 97878. |
Entry information
| Entry name | ACER2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q5QJU3 Secondary accession number(s): A2A3R8 Q71RD2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| SIMILARITY comments Index of protein domains and families |

Clusters with


